PubRank

Khaldoun Kerrou

Author PubWeight™ 33.20‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer. Nucl Med Commun 2012 2.07
2 Contralateral axillary sentinel lymph node drainage in breast cancer: a case report. J Surg Oncol 2004 1.60
3 Is 18F-fluorocholine-positron emission tomography/computerized tomography a new imaging tool for detecting hyperfunctioning parathyroid glands in primary or secondary hyperparathyroidism? J Clin Endocrinol Metab 2014 1.26
4 PET/CT in patients with hepatocellular carcinoma using [(18)F]fluorocholine: preliminary comparison with [(18)F]FDG PET/CT. Eur J Nucl Med Mol Imaging 2006 1.21
5 Detection of hepatocellular carcinoma with PET/CT: a prospective comparison of 18F-fluorocholine and 18F-FDG in patients with cirrhosis or chronic liver disease. J Nucl Med 2010 1.18
6 FDG PET/CT findings in a case of myositis ossificans circumscripta of the forearm. Clin Nucl Med 2011 0.97
7 Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors? J Nucl Med 2006 0.96
8 A Pilot Comparison of 18F-fluorocholine PET/CT, Ultrasonography and 123I/99mTc-sestaMIBI Dual-Phase Dual-Isotope Scintigraphy in the Preoperative Localization of Hyperfunctioning Parathyroid Glands in Primary or Secondary Hyperparathyroidism: Influence of Thyroid Anomalies. Medicine (Baltimore) 2015 0.94
9 Laparoscopic resection of occult metastasis using the combination of FDG-positron emission tomography/computed tomography image fusion with intraoperative probe guidance in a woman with recurrent ovarian cancer. Gynecol Oncol 2005 0.92
10 Impact of fluorodihydroxyphenylalanine-18F positron emission tomography on management of adult patients with documented or occult digestive endocrine tumors. J Clin Endocrinol Metab 2009 0.92
11 Basal asynchrony and resynchronization with biventricular pacing predict long-term improvement of LV function in heart failure patients. Pacing Clin Electrophysiol 2003 0.91
12 [18F]FDG in recurrent breast cancer: diagnostic performances, clinical impact and relevance of induced changes in management. Eur J Nucl Med Mol Imaging 2004 0.91
13 Endometriosis with FDG uptake on PET. Eur J Obstet Gynecol Reprod Biol 2004 0.88
14 Positron emission tomography with [(18)F]FDOPA and [(18)F]FDG in the imaging of small cell lung carcinoma: preliminary results. Eur J Nucl Med Mol Imaging 2003 0.88
15 18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type. Eur J Nucl Med Mol Imaging 2013 0.88
16 Diffuse spine involvement in sarcoidosis with sternal lytic lesions: two case reports. Spine (Phila Pa 1976) 2007 0.88
17 Peritoneal tuberculosis revealed by carcinomatosis on CT scan and uptake at FDG-PET. BJOG 2003 0.87
18 Detection of bronchioloalveolar cancer by means of PET/CT and 18F-fluorocholine, and comparison with 18F-fluorodeoxyglucose. Nucl Med Commun 2010 0.86
19 Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: comparison with 18F-fluoride uptake. Clin Nucl Med 2013 0.85
20 A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection. Nucl Med Commun 2012 0.84
21 [Clinical usefulness of positron emission tomography in prostate cancer]. Presse Med 2007 0.84
22 F-18 FDG PET/CT findings in pulmonary necrotizing sarcoid granulomatosis. Clin Nucl Med 2010 0.83
23 6-[F-18]fluoro-L-DOPA positron emission tomography in the imaging of Merkel cell carcinoma: preliminary report of three cases with 2-deoxy-2-[F-18]fluoro-D-glucose positron emission tomography or pentetreotide-(111In) SPECT data. Mol Imaging Biol 2006 0.83
24 Impact of FDG-PET to detect recurrence of head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 2007 0.83
25 18F-choline PET/CT for initial staging of advanced prostate cancer. AJR Am J Roentgenol 2006 0.81
26 Positron emission tomography/computed tomography imaging of residual skull base chordoma before radiotherapy using fluoromisonidazole and fluorodeoxyglucose: potential consequences for dose painting. Int J Radiat Oncol Biol Phys 2012 0.81
27 Limits of lymphoscintigraphy for sentinel node biopsy in women with endometrial cancer. Gynecol Oncol 2008 0.79
28 Limits of day-before lymphoscintigraphy to localize sentinel nodes in women with cervical cancer. Ann Surg Oncol 2008 0.79
29 [PET and malignant cerebral tumors]. Presse Med 2006 0.79
30 Impact of FDG PET/CT in the staging and the follow-up of anal carcinoma. Int J Colorectal Dis 2011 0.77
31 Reactive amyloidosis complicated by end-stage renal disease 28 years after liquid silicone injection in the buttocks. BMJ Case Rep 2012 0.77
32 Ventricular coupling of electrical and mechanical dyssynchronization in heart failure patients. Pacing Clin Electrophysiol 2002 0.76
33 [Sentinel lymph node biopsy in cervical and endometrial cancers: a feasibility study]. Bull Cancer 2004 0.76
34 Can we achieve a radionuclide radiation dose equal to or less than that of 99mTc-hydroxymethane diphosphonate bone scintigraphy with a low-dose 18F-sodium fluoride time-of-flight PET of diagnostic quality? Nucl Med Commun 2013 0.76
35 FDOPA PET has clinical utility in brain tumour imaging: a proposal for a revision of the recent EANM guidelines. Eur J Nucl Med Mol Imaging 2007 0.76
36 Feasibility and performance of lymphoscintigraphy in sentinel lymph node biopsy for early cervical cancer: results of the prospective multicenter SENTICOL study. Ann Nucl Med 2014 0.75
37 Safety of 18F-DOPA injection for PET of carcinoid tumor. J Nucl Med 2006 0.75
38 Silicone Granuloma in the Buttocks Incidentally Detected by 18F-FDG PET/CT 30 Years After Free Liquid Silicone Injections. Clin Nucl Med 2016 0.75
39 [FDG-PET in localization of cancers of unknown primary origin]. Presse Med 2006 0.75
40 Whole-body 18F-fluorocholine (FCH) PET/CT and MRI of the spine for monitoring patients with castration-resistant prostate cancer metastatic to bone: a pilot study. Clin Nucl Med 2014 0.75
41 Fluorine-18 fluorodeoxyglucose with positron emission tomography revealed bone marrow involvement in sarcoidosis patients with anaemia. Respiration 2009 0.75
42 [The contribution of PET to radiation treatment planning]. Bull Cancer 2007 0.75
43 [PET and digestive cancers]. Presse Med 2007 0.75
44 [PET in primary pulmonary or pleural cancer]. Presse Med 2006 0.75
45 [PET in thyroid cancers]. Presse Med 2006 0.75
46 Fluorodeoxyglucose imaging using a coincidence gamma camera to detect head and neck squamous cell carcinoma and response to chemotherapy. Ann Otol Rhinol Laryngol 2002 0.75
47 [Positron emission tomography (PET) in gastrointestinal cancer]. Gastroenterol Clin Biol 2006 0.75
48 Detection of recurrent colorectal carcinoma by 18F-FDG: comparison of the clinical performances of FDG PET and FDG CDET. Nucl Med Commun 2004 0.75
49 [FDG PET and its impact on patient's management in oncology]. Presse Med 2006 0.75
50 [PET in head and neck cancers]. Presse Med 2006 0.75